Still a Pandemic of the Unvaccinated. Seniors not boosted with the bivalent vaccine have 5 times the probability of being hospitalized. First real-world data show Omicron booster kept seniors out of hospitals https://www.latimes.com/science/sto...omicron-booster-kept-seniors-out-of-hospitals In the first real-world test of vaccine boosters specially designed to protect against the Omicron variant, Israeli researchers have found that people 65 and over who got an updated jab were 81% less likely to be hospitalized with COVID-19 than those who did not. The preliminary findings, posted to a website established by the British medical journal Lancet, have not yet been through the peer-review process. They are based on the medical records of more than 85,000 people 65 and over who got a dose of Pfizer and BioNTech’s retooled mRNA booster and more than 537,000 others in the same age group who did not get the shot. During a 70-day period between late September and mid-December, 297 people in the larger, unboosted group were hospitalized and 73 died. During the same period, six people in the boosted group were hospitalized and one died. When the Israeli researchers crunched the numbers, they determined that the boosters reduced a recipient’s risk of hospitalization to about one-fifth that of an unboosted person. The Israeli findings also suggest that the new boosters may help in fending off COVID-19 deaths as well as hospitalizations. As a statistical matter, however, the small numbers of deaths in the study population make it difficult to draw such a conclusion with high confidence. The study’s authors, who hail from Israel’s Clalit Health Services and several Israeli universities, wrote that their findings “highlight the importance of bivalent-booster vaccination in this high-risk population, and the necessity to increase efforts to encourage eligible people to be vaccinated.” The Omicron-specific vaccines are called “bivalent” boosters because they use two prompts to train the immune system to recognize the SARS-CoV-2 coronavirus. In addition to going after the original strain that was detected in December 2019, they also target the Omicron variant, which began circulating in November 2021. The new formula was devised in response to concerns that waning immunity, and a changing virus, had compromised the protection of people who had been fully vaccinated and once boosted against COVID-19. Even before it was rolled out, however, the Omicron variant began spinning myriad subvariants, raising new concerns about how effectively bivalent boosters would continue to protect. Since COVID-19 vaccines first became available, Israel has been closely studied because it quickly immunized most of its population with Pfizer’s mRNA vaccine. In Israel, the bivalent booster shots have been prioritized for people who are at high risk for developing severe cases of COVID-19 if infected, and for those 65 and older. The United States, however, has taken a different approach. The CDC recommends that all Americans who are at least 6 months old get an Omicron-specific shot from either Pfizer or Moderna if they are eligible. Though the shots are available for free to virtually all in the United States, many Americans have greeted the new offerings with indifference. Only 15.4% of Americans 5 and older have gotten a bivalent booster dose, according to the latest data from the CDC. “People are complacent,” said Dr. Oliver Brooks, chief medical officer of Watts Healthcare in Los Angeles. It’s one thing to counter vaccine hesitancy, he said, and it remains important to ensure easy access for all. But when people become confident they’ll be fine without boosters, public health officials have an uphill battle, he added. “What we do know is, you’re better off vaccinated and boosted. Period,” Brooks said. Interest in bivalent boosters has been greater among older adults, whose vulnerability to severe COVID-19 is clearly higher. Some 31.8% of Americans 65 and older have gotten the updated shots, but rates vary widely from state to state. In California, nearly 43% of seniors have rolled up their sleeves, and in Vermont, about 70% of seniors have done so. But in Mississippi, only 19% of senior citizens have received it. Louisiana and Alabama are close to the bottom too, with roughly 21% of seniors getting it. Dr. Paul Offit, a vaccine expert at Children Hospital of Philadelphia, said the Israeli study makes a good case that for those 65 and older, the bivalent booster helps. But he said it does little to make the case that younger people will benefit from the shots. The fact that the average age of the Israelis studied was just over 75 raises the possibility that the boosters provide the greatest protection to the “elderly elderly,” he said.
Reality seems to elude you. It's so nice to have Misterkel and you all posting the same anti-vax bullshiat you find on social media over and over again on ET. Unfortunately all of it is either false or totally out of context. Here is the official web pages for New South Wales. https://covidbaseau.com/nsw/#line8 https://www.health.nsw.gov.au/Infectious/covid-19/Pages/weekly-reports.aspx https://www.health.nsw.gov.au/Infectious/covid-19/Documents/weekly-covid-overview-20221231.pdf Let's give you a glimpse of reality.
mockingbird News Ninnies, LOL! Wind em up and they read whatever is in front of them. I see a job for KC's Rubber Dolls!
Just keep in mind that your autopsy is 20 times more likely if you are unvaccinated. COVID Autopsies Reveal The Virus Spreading Through The 'Entire Body' https://www.sciencealert.com/covid-autopsies-reveal-the-virus-spreading-through-the-entire-body COVID-19 is defined as a respiratory infection, but the effects of the novel coronavirus are certainly not confined to any one organ. Dozens of recent autopsies show persistent evidence of SARS-CoV-2 throughout the body, including in the lungs, the heart, the spleen, the kidneys, the liver, the colon, the thorax, muscles, nerves, the reproductive tract, the eye, and the brain. In one particular autopsy, remnants of the novel coronavirus were found in the brain of a deceased patient 230 days after they first started showing symptoms. "Our data indicate that in some patients SARS-CoV-2 can cause systemic infection and persist in the body for months," conclude the authors of the study, led by researchers at the United States National Institutes of Health (NIH). In the past, autopsies on those who have contracted COVID-19 have shown preliminary signs of multi-organ spread, with genetic remnants of the virus showing up in a myriad of tissues, organs, and fluids. In July of 2020, further autopsies showed evidence of blood clots in nearly every vital organ of those who had contracted COVID-19. The new research from the NIH now replicates and confirms these results in greater detail than ever before. The researchers suggest their newest findings are the most comprehensive analysis to date on the cellular persistence of SARS-CoV-2 in the human body. The study involved 44 autopsies, in which researchers carefully detected and quantified the level of messenger RNA from SARS-CoV-2 in 85 locations and fluids. This genetic information is indicative of where the virus might have been replicating during a person's life. From autopsies carried out in April 2020 to March 2021, researchers found older, unvaccinated individuals who died from COVID-19 showed abundant signs of SARS-CoV-2 replication in a total of 79 locations and body fluids. What's more, some of the changes were apparent within two weeks after symptoms first began to appear. Interestingly, while the lungs showed the most inflammation and injury, the brain and other organs did not often show significant tissue changes "despite substantial viral burden". The authors aren't sure why that is. It could be, for example, that the human immune system is not as good at targeting these other locations compared to the lungs. In later stages of COVID-19 recovery, researchers found evidence that the lungs were less infected than they were at first, while other locations did not show nearly as much improvement. "Our results show that although the highest burden of SARS-CoV-2 is in respiratory tissues, the virus can disseminate throughout the entire body," the researchers conclude. How the virus spreads so far and wide is another mystery that needs to be solved. The autopsies in the current study did not often show detectable viral remnants in blood plasma, which suggests the pathogen may be traveling around via other means. Understanding the way in which SARS-CoV-2 spreads and persists in the human body could reveal a lot about why some patients suffer from long-haul COVID-19. The NIH study did not experiment with long COVID patients specifically, but the results are relevant to possible treatment plans. Antivirals, like Paxlovid, for instance, could help the human immune system clear viral cells from tissues, organs, and fluids that may be otherwise difficult to reach. Perhaps, in turn, that can help reduce lingering symptoms. "We're hoping to replicate the data on viral persistence and study the relationship with long COVID," says one of the authors, Stephen Hewitt, from the National Cancer Institute. "Less than a year in we have about 85 cases, and we are working to expand these efforts." The study was published in Nature.
Unvaccinated COVID patients 'at greater risk of death' for at least 18 months after infection Unvaccinated COVID patients retain a greater risk of death and cardiovascular disease for at least 18 months after infection, new research suggests. https://news.sky.com/story/unvaccin...r-at-least-18-months-after-infection-12789515
The vaccine mandate for health care workers is in place nationally and upheld by the Supreme Court. FACTS MATTER. Biden Health-Care Vaccine Mandate Survives Supreme Court Appeal https://news.bloomberglaw.com/us-la...vaccine-mandate-survives-supreme-court-appeal